Healthcare & Life Sciences
GT Apeiron Therapeutics
Chinawww.gt-apeiron.com
GT Apeiron Therapeutics is a Healthcare & Life Sciences startup based in China, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About GT Apeiron Therapeutics
GT Apeiron Therapeutics is a company headquartered in China. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
GT Apeiron Therapeutics is a clinical-stage small molecule biotech company developing biomarker-driven cancer therapeutics, including a PRMT5 inhibitor currently in Phase 1 clinical trials and a KIF18A inhibitor with a differentiated profile.
Explore GT Apeiron Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.